A superposition/convolution GPU-accelerated dose computation algorithm (the Calculator) has been recently incorporated into commercial software. The algorithm requires validation prior to clinical use. Three photon energies were examined: conventional 6 MV and 15 MV, and 10 MV flattening filter free (10 MVFFF). For a set of IMRT and VMAT plans based on four of the five AAPM Practice Guideline 5a downloadable datasets, ion chamber (IC) measurements were performed on the water-equivalent phantoms. The average difference between the Calculator and IC was À0.3 AE 0.8% (1SD).
The same plans were projected on a phantom containing a biplanar diode array. We used the forthcoming criteria for routine gamma analysis, 3% dose-error (global (G) normalization, 2 mm distance to agreement, and 10% low dose cutoff). The c (3%G/ 2 mm) average passing rate was 98.9 AE 2.1%. Measurement-guided three-dimensional dose reconstruction on the patient CT dataset (excluding the Lung) resulted in a similar average agreement rate with the Calculator: 98.2 AE 2.0%. The mean c (3%G/2 mm) passing rate comparing the Calculator to the TPS (again excluding the Lung) was 99.0 AE 1.0%. Because of the significant inhomogeneity, the Lung case was investigated separately. The calculator has an alternate heterogeneity correction mode that can change the results in the thorax for higher-energy beams (15 MV) . As this correction is nonphysical and was optimized for simple slab geometries, its application leads to mixed results when compared to the TPS and independent Monte Carlo calculations, depending on the CT dataset and the plan. The Calculator vs. TPS 15 MV Guideline 5a
IMRT and VMAT plans demonstrate 96.3% and 93.4% c (3%G/2 mm) passing rates respectively. For the lower energies, which should be predominantly used in the thoracic region, the passing rates for the same plans and criteria range from 98.6 to 100%.
Overall, the Calculator accuracy is sufficient for the intended use.
| INTRODUCTION
It is the current standard of practice in the United States that for each radiotherapy treatment course involving intensity modulated, inversely planned dose delivery (IMRT/VMAT), a patient-specific quality assurance procedure has to be performed to ensure that the calculated dose distribution is reasonably accurate. 1 A simple point dose verification is considered sufficient in conventional (forwardplanning) therapy. 2 Acknowledging the complexity and temporal nature of the dose calculation and delivery of modulated beams, dose comparison has to be more extensive. Historically, patient specific IMRT QA was performed by projecting the treatment plan on a phantom containing a dosimeter and comparing the measured sample of the 3D dose distribution with calculations. 3 As the inversely planned techniques matured and became the mainstay of radiotherapy, alternative dose verification techniques started to be actively explored. Those included electronic portal imaging device (EPID)-based dosimetry, 4, 5 calculation-based reconstruction from the accelerator log files, 6, 7 including harvesting aperture shapes (but not fluence) from the EPID, 8 or just a straightforward recalculation by an independent dose engine. [9] [10] [11] [12] [13] Each method has its advantages and disadvantages, and none is capable of catching every possible mode of failure, 10 including catastrophic events.
In this article, we critically examine and validate a fast, independent 3D dose calculator as an additional tool that potentially could be incorporated in the IMRT/VMAT QA process. This calculator is the dose engine used in the commercial products (Sun Nuclear Corp., Melbourne, FL, USA) for purely calculational (DoseCHECK) or empirically guided (PerFRACTION) dose reconstruction. For the former, the DICOM RT Plan from the primary treatment planning system (TPS) serves as the input for the verification dose calculation on the patient CT dataset. In the latter, the aperture shapes recorded by the EPID during beam delivery are used to generate the MLC control points. Simultaneously, corresponding monitor unit and angle progressions are harvested from the accelerator log files for dose calculation. A common step to both the calculational and the semiempirical approaches is dose calculation by a Superposition/Convolution (S/C) technique. Obviously, the accuracy of the dose calculation engine employed in these products is of paramount importance for their clinical performance and deserves a thorough investigation.
Experimental validation of the algorithm is the only goal of this manuscript. The data from this manuscript was used in the Sun Nuclear Corp. White Paper. 14 We do not attempt to weigh in on an ongoing discussion 15, 16 of the relative merits of measurement-based vs. software-based patient-specific IMRT QA methods.
2 | ME TH ODS 2.A | Calculator description
2.A.1 | Dose calculation algorithm
The approach was originally developed and described in detail by Jacques et al. 17 It is a variant of a S/C style dose calculation [18] [19] [20] adapted for fast execution on the graphics processing unit (GPU) card(s). As with all implementations of S/C methods, the calculation consists of three steps: fluence calculation, total energy released per unit mass (TERMA) calculation, and, finally, superposition.
The fluence calculation is responsible for simulating radiation transport within the linear accelerator treatment head. There are separate sources used to model primary, extra focal (scatter), and electron contamination radiation. The primary and extrafocal sources each have their own spectrum and arbitrary radial intensity profile.
Jaws and MLC characteristics, including properties such as MLC tongue-and-groove thickness and MLC leaf end curvature, are accounted for explicitly.
In the next step, fluence is transported through the patient to compute primary energy released in the volume (TERMA). The material composition of the patient volume is determined using the CT dataset along with a user-provided CT-to-relative electron density (ED) conversion 20 while electron density is used to attenuate the primary fluence through the patient along the heterogeneity-corrected ray-trace path. TERMA is calculated every 2°for VMAT plans.
Finally, the superposition step spreads the TERMA by the energy deposition kernel to determine the final dose at each point. 19 The kernel is derived from high resolution (1 mm, 1°)
Monte Carlo (MC) simulations in the water phantom. A cumulativecumulative kernel is used to minimize voxelization effects. 18 The energy deposition kernel scales with electron density, which differentiates the superposition approach from the traditional convolution. 17 The kernel's angular dependence is discretized using a collapsed cone approximation, 21 and both kernel tilting and beam hardening are accounted for. The superposition calculation for VMAT is performed every 5°, which still allows for acceptable accuracy of the overall calculation. 17 As TERMA calculations are substantially faster than superposition calculations, using a high TERMA but low superposition angular resolutions increases the speed of VMAT calculations. 
2.B | Validation
The main goal of this paper is independent validation of the just described algorithm. To cover a reasonably wide range of energies and different beam types, three photon energies were examined: 
2.B.1 | Basic beams on the water phantom
The dose distributions on the synthetic CT phantom of unit density were compared to the primary TPS for a series of open square fields recommendations. To achieve similar agreement in Pinnacle, the calculation mode had to be switched to the homogeneous water phantom. Otherwise, a synthetic CT phantom of unit density is treated in Pinnacle as being slightly different from water, due to the CT to material assignment method. 26 After proper reference dose was confirmed, the Pinnacle and Calculator dose grids (2 mm voxel size)
were loaded in 3DVH software v. 3.3 (Sun Nuclear Corp) and compared using gamma analysis using 2% (global normalization) dose-error and 2 mm distance to agreement criteria, with low-dose cut-off at 10% of the maximum (2%G/2 mm/10%).
2.B.2 | Slab inhomogeneities
The calculator has two modes for handling significant inhomogeneities (e.g., lung), requiring two separate beam models. The basic S/C approach was described above. Alternatively, an additional cor- Monte Carlo calculations were performed with PRIMO, a radiotherapy graphical interface to PENELOPE code. 28 Manufacturer-provided IAEA-compliant phase space files for the TrueBeam accelerator 29 were used in lieu of modeling the accelerator head above the movable jaws. The current version of those files provides a phase space on a horizontal plane 27 cm downstream from the source. The number of histories was sufficient to achieve 1% statistical uncertainty (two standard deviations) at the dose level above 50% of the maximum in the phantom. An in-house script was written to convert PRIMO ASCII dose files into DICOM RT-compliant dose objects. The PRIMO simulations were validated against Pinnacle for the 10 9 10 cm 2 fields on the water phantom, at the 2%/ 2 mm level.
2.B.3 | IMRT/VMAT Planning and delivery
All measurements were done on a TrueBeam v 2.0 linear accelerator equipped with a 120-leaf Millennium MLC (Varian Medical Systems).
The IMRT and VMAT plans were developed based on the Guideline 5a Report library of test plans. 23 They included four realistic plans from the available downloadable datasets: Anal, Head and Neck (H&N), Abdomen and Lung. The concept behind these Guideline 5a cases is to provide challenging but clinically relevant goals, with large targets and tight constraints, resulting in highly modulated plans pushing the accuracy limits of the TPS calculation algorithms.
They were previously used for large, inter-institutional plan studies similar to the pilot study described by Nelms et al. 30 Both VMAT (Pinnacle SmartArc 31, 32 ) and static gantry, segmented IMRT (Pinnacle Direct Machine Parameters Optimization 33 )
plans were created for each case. Optimization was done for the 6 MV beams, and other energies were simply recalculated for the same control points (CP). The H&N and Anal VMAT plans used two arcs, while the remaining plans used one. The VMAT plans were calculated with 2°angular CP increment. The IMRT plans used seven to nine equidistant gantry angles. Three of four plans (except the Abdomen), had targets too large to be encompassed for conventional
IMRT with a single set of the MLC carriage positions, due to the limitations of the maximum leaf extension. They were instead planned with the "wide-field" IMRT technique, where the leaves are allowed to nearly close inside the treatment field, not necessarily under the X jaws, but those leaf abutment points move across the field from segment to segment to avoid excessive exposure at any one location in the patient. In all cases, a uniform 2.5 mm dose grid resolution was used for both the TPS and the Calculator.
2.B.4 | The Calculator vs. point dose measurements
For the three of four cases (excluding the Lung), the plans were pro- there is no guarantee that the different dose calculation algorithms would agree. Therefore, the Lung case was excluded from the ACPDP analysis and was investigated separately as described in the following sections.
The same 3%G/2 mm gamma analysis criteria were used, supplemented by 2%G/2 mm data. Since the discrepancies in the buildup region are expected, and are effectively ignored in the traditional phantom measurements by the virtue of the active volume placement at depth, the analyzed volumes here and in the next section were filtered to exclude the outermost 7 mm of the body on the CT datasets.
2.B.7 | The Calculator vs. primary TPS on the patient CT (Not including Lung)
The 3D Calculator doses on the patients' datasets were directly compared to the corresponding Pinnacle dose distributions using the same methodology as described above. This configuration represents the intended use of the Calculator. The Lung case is not included in this comparison, to isolate differences in accounting for heterogeneities.
2.B.8 | The Calculator vs. primary TPS (Lung)
Additional comparisons were made for the Lung plan to better understand the differences, and their practical significance, between the two versions of the Calculator heterogeneity corrections. Unlike with the previous three datasets, special tests were done for the Lung plan. In addition to comparisons on the patient dataset, the plans were recalculated on the Thorax phantom with Pinnacle, no-HCS, and HCS versions of the Calculator. The phantom provides clear-cut interfaces and uniform low-density regions, which were expected to emphasize the differences between various algorithms.
Comparisons with MC were also performed. Unfortunately, it is not practical to recalculate segmented beams with PRIMO. Instead, we created a simple 5-beam coplanar plan which could be calculated on the Thorax phantom with identical parameters with every S/C algorithm and MC. All beams were equally weighted and the MLC apertures surrounded the 4 cm diameter spherical target with a 0.7 cm margin. The relative MC calculations were normalized to the isocenter dose measured with an IC. The resulting dose grids were compared in 3DVH software. 
| RESULTS

3.A | Basic beams on the water phantom
3.B | Slab inhomogeneities
The central axis PDDs on the lung slab phantom for a small (2 9 2 cm 2 ) field are shown in Fig. 2 . For the 15 MV beam ( Fig. 2(a) ) one can see the difference in lung dose between Pinnacle, Non-HCS Calculator, and HCS-corrected Calculator. The HCS correction improved agreement with Pinnacle and MC in the simple geometry, as reported previously. 27 For the lower energies (Figs. 2(b) and2(c) ), the difference between Pinnacle and the standard Calculator mode in the inhomogeneity was minimal (< 1.3%
and 0.7% of D max for 10 MVFFF and 6 MV, respectively), and both were sufficiently close to MC. Therefore, the effect of the HCS correction was not further studied for those energies. The larger fields (not shown) exhibited the same trends but to a smaller degree.
3.C | The Calculator vs. point dose measurements
For the point doses in the homogeneous phantoms or portions thereof (e.g., excluding the target location in the Thoracic phantom), the mean Calculator vs. the IC difference was À0.3 AE 0.8% (1 SD).
The range was from À2.0 to 1.0%. For the plans based on the Guideline 5a Lung case as delivered to the Thorax phantom, the 15MV IMRT and VMAT plans showed 2.8 and 4.0% difference from the IC in the target respectively. Pinnacle doses at the same point were within 1.4% of the IC. With the HCS correction applied, the disagreement was reduced to À0.7% and 1.6% for the 15 MV IMRT and VMAT plans, respectively, while the change in the homogeneous portion of the phantom was minimal. The findings for the Lung plans with both lower energies were unremarkable at both measurement points in the Thorax phantom.
3.D | The Calculator vs. biplanar diode array (homogeneous phantom)
The average c (3%G/2 mm) and c (2%G/2 mm) passing rates of the Calculator against the Delta 4 measurements were 98.9 AE 2.1% and 96.1 AE 6.4% respectively. The Calculator produced c (3%G/2 mm) agreement rates with the Delta 4 measurements above 95% in all the studied cases but two, and all were above 90% (Fig. 3) . Both lower passing rates are associated with the 6 MV Anal case plans (94.8%
for VMAT and 91.4% for IMRT) (Fig. 3 ) 
3.E | The Calculator vs. 3D measurement-guided dose reconstruction (not including lung)
In the next step, the agreement between the measurement-guided dose reconstruction on the patient datasets using the ACPDP method, and the Calculator followed the same trend as the direct comparison on the homogeneous phantom (compare Figs. 4 and 3) .
The Guideline 5a Lung plans were excluded from the comparison. 
3.F | The Calculator vs. primary TPS on the patient CT (not including lung)
The mean c (3%G/2 mm) and c (2%G/2 mm) passing rates comparing the Calculator to Pinnacle were 99.0 AE 1.0% and 97.5 AE 2.4%, respectively. The corresponding ranges are 96.3 to 100% and 91.6 to 99.7% respectively. The frequency distributions are shown in Fig. 6 . The three instances with the c(2%G/2mm) passing rates below 95% are all associated with higher energies on the H&N dataset, which is unlikely to be seen in practice. Of note, the patterns of c (2%G/2 mm) analysis failure against ACPDP for the 6 MV IMRT Anal plan are visually similar between the Calculator and ACPDP (Fig. 5) . Not surprisingly the 2%G/2 mm gamma passing rate between the Calculator and TPS is 99.1%.
Central axis PDDs on the lung slab phantom for the 2 9 2 cm 2 field: 15MV (a), 10 MVFFF (b), and 6MV (c).
Frequency distribution of the c-analysis passing rates comparing the Calculator to the Delta4 for all Guideline 5a test cases and energies. N = 24.
Frequency distribution of the c-analysis passing rates comparing the Calculator to ACPDP measurement-guided dose reconstruction on the patient datasets for Guideline 5a test cases excluding the Lung (all energies). N = 18.
3.G | The calculator vs. primary TPS (lung)
The agreement level between the Calculator and Pinnacle for the Lung plan is energy-, calculation mode-, and dataset-dependent, which necessitates a more detailed discussion. As can be seen in Table 1 , passing rates on the Guideline 5a Lung dataset decrease as the beam energy increases, which is particularly clear with the 2% dose-error threshold. The HCS correction applied to the 15 MV plans did not lead to an improvement. The data for the same plans recalculated on the Thorax phantom are presented in Table 2 
| DISCUSSION
The calculator was put through a series of tests representing a subset of those required for commissioning of a primary TPS dose engine. 23, 38 The mean IC point dose error in the homogeneous phantoms is well below the 1.5% expectation. 23, 39 According to the forthcoming recommendation on IMRT QA criteria, 95% of the points on a homogeneous phantom passing the 3%G/2 mm/10% gamma analysis should constitute the tolerance limit, with the action limit set at 90% (private communication). While no compelling data exist to suggest that 3%/2 mm criteria hold an advantage in sensitivity/specificity over 3%/3 mm, reducing the distance-to-agreement and~1 g/cm 3 densities. In that configuration, the HCS-corrected
Calculator showed substantial improvement in agreement with Pinnacle for the modulated plans (Table 2) . While Pinnacle was widely tested in lung, it cannot be considered the standard and in fact has been shown to be rather inaccurate in certain situations. 34 Unfortu- There is no guidance document yet on IMRT dose distribution verification by independent calculation, with or without some empirical input. In the meantime, it seems reasonable to apply the forthcoming experimental verification criteria in most situations.
However, there are additional uncertainties related to calculating dose in lung, and appropriate criteria need to be developed, perhaps such as the varying action limits based on the algorithm similarity and case complexity established for secondary checks in non-IMRT radiotherapy. 2 Finally, we must point out that subtle dose differences could stem from the way the different algorithms calculate or report dose to different tissue types. 41 For example, both Pinnacle and the Calculator determine the tissue type from their CT to density conversion tables, using the mass and electron densities, respectively. This tissue assignment is then used to look up the appropriate mass energy absorption coefficient for TERMA calculations. The Pinnacle assignment table does not include water, while in the Calculator CT voxels corresponding to approximately unit density would resolve to water. This difference in dose reporting could potentially lead to up to~1% error even on an ideal unit-density phantom, and is hard to control for a patient CT dataset.
T A B L E 2 Gamma analysis passing rates comparing the Calculator to Pinnacle for the same plans as in 
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